Cortronix Biomedical Advancement Technologies Inc. | 2013 | FY | 3


Development- Stage

 

CorTronix Biomedical Advancement Technologies Inc. is a development-stage company as defined in Accounting Standards Codification (“ASC”) 915 Development-Stage Entities, as it is developing an advanced telemetric system used to transmit, analyze, report and store all types and variations of physiological studies. There have been no revenues from planned principal operations or sales from August 3, 2012 (date of inception through August 31, 2013. Consequently, cumulative amounts are presented in these consolidated financial statements.


us-gaap:DevelopmentStageEnterpriseGeneralDisclosuresTextBlock